This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Following through on earlier statements that it planned to be aggressive in the mergers and acquisitions market this year, Qiagen last week signed a deal to acquire sample-separation technology company eGene in a cash and stock deal valued at around $34 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.